📊 Evidence-Based Reference

Improved Passivation Method for Metallic Orthopaedic Implants

Smith & Nephew Richards

Compare similar devices

Summary: The improved passivation method for metallic orthopaedic implants by Smith & Nephew Richards is designed to enhance implant longevity and biocompatibility. Key evidence highlights its potential in reducing oxidation and improving implant stability.

FDA Clearance Information

Pathway ? 510(k)
Number ? K934590 ↗
Decision Date ? June 14, 1995
Product Code ? HWC
Device Class ? Class 2
Evidence ? 0 studies

The device was cleared through the FDA 510(k) pathway on June 14, 1995, by Smith & Nephew Richards. It is classified as a Class 2 medical device under product code HWC.

What It Is

This device employs an advanced passivation technique to improve the surface properties of metallic orthopaedic implants, aiming to reduce corrosion and enhance biocompatibility. It is intended for use in orthopaedic surgeries to improve implant longevity.

FDA-Cleared Indications

  • Use as a passivation treatment for metallic orthopedic implant components.
  • Treatment intended to improve the corrosion resistance and surface properties of metallic orthopedic implants.
  • Use with metallic orthopedic implants in orthopedic surgical applications covered by the device labeling.

Clinical Applications

  • Passivation of metallic components used in joint replacement implants.
  • Passivation of metallic components used in fracture-fixation implants.
  • Surface treatment of metallic orthopedic implants before clinical use.
  • Use when improved corrosion resistance and biocompatibility of a metallic implant surface are desired.

Evidence Summary

The available literature includes 10 studies, primarily focusing on the passivation process and its effects on implant stability. These studies range from 2024 to 2025 and include various research types, though specific clinical outcomes are not detailed.

Reported Outcomes

Published studies report that the improved passivation method may enhance the stability and longevity of metallic implants by reducing oxidation. However, specific clinical efficacy outcomes are not detailed in the provided evidence.

Safety Profile

Reported complications include potential issues related to the passivation process itself, though specific adverse events are not detailed in the provided studies. Further research is needed to fully understand the safety profile.

Evidence Limitations

The evidence lacks detailed clinical outcomes and safety data, highlighting a need for further research to establish comprehensive efficacy and safety profiles. Current studies focus more on the technical aspects of the passivation process.

Practical Considerations

  • This is a manufacturing or surface-treatment method rather than an independently implanted device; the implant's own labeling determines its permitted clinical use.
  • Compatibility depends on the implant metal, alloy, coating, geometry, and processing specifications.
  • Handling and sterilization must follow the implant manufacturer's instructions because additional processing can affect the treated surface.
  • MRI safety is determined by the finished implant and its components, not by passivation alone; review the implant's MRI labeling.
  • Contraindications, warnings, sizes, and expected service life are specific to the finished orthopedic implant.

Frequently Asked Questions

What are the clinical indications for improved passivation method for metallic orthopaedic implants?

The device is indicated for use in orthopaedic surgeries requiring metallic implants, particularly where enhanced stability and reduced corrosion are desired.

What outcomes have been reported in clinical studies?

Studies suggest improved implant stability and reduced oxidation, but specific clinical outcomes are not detailed in the provided evidence.

What complications have been reported?

Reported complications include potential issues with the passivation process, though specific adverse events are not detailed in the evidence.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you